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Abstract
Introduction: Estimation of kidney function in critically ill patients with acute kidney injury (AKI), is important for
appropriate dosing of drugs and adjustment of therapeutic strategies, but challenging due to fluctuations in kidney
function, creatinine metabolism and fluid balance. Data on the agreement between estimating and gold standard
methods to assess glomerular filtration rate (GFR) in early AKI are lacking. We evaluated the agreement of urinary
creatinine clearance (CrCl) and three commonly used estimating equations, the Cockcroft Gault (CG), the
Modification of Diet in Renal Disease (MDRD) and the Chronic Kidney Disease Epidemiology Collaboration (CKD-
EPI) equations, in comparison to GFR measured by the infusion clearance of chromium-ethylenediaminetetraacetic
acid (51Cr-EDTA), in critically ill patients with early AKI after complicated cardiac surgery.
Methods: Thirty patients with early AKI were studied in the intensive care unit, 2 to 12 days after complicated
cardiac surgery. The infusion clearance for 51Cr-EDTA obtained as a measure of GFR (GFR51Cr-EDTA) was calculated
from the formula: GFR (mL/min/1.73m2) = (51Cr-EDTA infusion rate × 1.73)/(arterial 51Cr-EDTA × body surface area)
and compared with the urinary CrCl and the estimated GFR (eGFR) from the three estimating equations. Urine was
collected in two 30-minute periods to measure urine flow and urine creatinine. Urinary CrCl was calculated from
the formula: CrCl (mL/min/1.73m2) = (urine volume × urine creatinine × 1.73)/(serum creatinine × 30 min × body
surface area).
Results: The within-group error was lower for GFR51Cr-EDTA than the urinary CrCl method, 7.2% versus 55.0%. The
between-method bias was 2.6, 11.6, 11.1 and 7.39 ml/min for eGFRCrCl, eGFRMDRD, eGFRCKD-EPI and eGFRCG,
respectively, when compared to GFR51Cr-EDTA. The error was 103%, 68.7%, 67.7% and 68.0% for eGFRCrCl, eGFRMDRD,
eGFRCKD-EPI and eGFRCG, respectively, when compared to GFR51Cr-EDTA.
Conclusions: The study demonstrated poor precision of the commonly utilized urinary CrCl method for
assessment of GFR in critically ill patients with early AKI, suggesting that this should not be used as a reference
method when validating new methods for assessing kidney function in this patient population. The commonly
used estimating equations perform poorly when estimating GFR, with high biases and unacceptably high errors.
Introduction
Accurate assessment of kidney function in the critically
ill patient plays an important role in diagnosing acute
kidney injury (AKI); in the appropriate prescription and
dosing of drugs, whose elimination depends on renal
function; and in timely application of therapeutic strate-
gies. In clinical medicine, the concentration of creatinine
in serum is used daily as a marker for kidney function.
However, serum creatinine concentration may not be
suitable for this purpose as it is affected by factors other
than kidney function. Creatinine is metabolized from
creatine, which is released by the muscles, therefore
muscle mass and metabolic transformation of creatine
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have an impact on serum creatinine concentration [1].
In addition, age, gender and race all affect muscle mass
and, in turn, serum creatinine concentrations [2,3].
In critically ill patients with AKI, three main factors
influence the accuracy of serum creatinine as a marker of
kidney function: true kidney function, fluctuations in
creatinine production, and fluid balance. In critically ill
patients, creatinine production may be decreased because
of immobilization and malnutrition, or increased because
of catabolic illness. Increases in total body water, com-
mon in these patients, increases the distribution volume
of creatinine, and attenuates the increase in serum creati-
nine concentration caused by AKI [1,4-6]. Furthermore,
various drugs used to treat critically ill patients, such as
cimetidine and trimethoprim-sulfamethoxazole, are
known to compete with the active tubular secretion of
creatinine, and therefore to affect serum creatinine con-
centration [7,8]. Thus, daily changes in serum creatinine
poorly reflect changes in kidney function in patients with
AKI [4].
Glomerular filtration rate (GFR), measured using
exogenous substances such as inulin, iohexol, 123I-
iothalamate, diethylene triamine pentaacetic acid and
chromium-ethylenediaminetetraacetic acid (51Cr-
EDTA) as filtration markers, is considered as the gold
standard for assessment of renal function [9,10].
Unfortunately, measuring GFR with these markers is
expensive and complex, considerably outweighing their
high reliability and making them unsuitable for routine
use in the intensive care setting.
The second best method for assessment of renal func-
tion is urinary creatinine clearance (CrCl), which can be
computed from a timed urine collection (for example, a
24-hour urine collection) and blood sampling for serum
creatinine [11]. However, clearance methods require a
steady state situation, a criteria not always met in criti-
cally ill patients, where changes in the hemodynamic sta-
tus can result in dramatic changes in renal function over
a 24-hour urine collection period. Furthermore, accurate
timed collection of urine is cumbersome, and the main
source of error [12]. Finally, urinary CrCl may consider-
ably overestimate GFR because of tubular secretion of
creatinine [1,5].
GFR can also be assessed using estimating equations.
These equations include variables such as age, sex, race
and body weight, in addition to serum creatinine, as a sub-
stitute for muscle mass and they can therefore overcome
some of the limitations associated with using serum creati-
nine alone [9,13-15]. Estimating equations for GFR have
been developed in study populations consisting of patients
with chronic stable kidney disease and stable serum creati-
nine concentrations [13-15]. These equations are poorly
evaluated in critically ill patients with AKI and most often
they have been validated against urinary CrCl, instead of a
gold standard reference method, such as measurement of
GFR using an exogenous substance for a filtration marker.
Furthermore, data on the agreement between urinary CrCl
and gold standard GFR in critically ill patients with early
AKI are lacking.
The aim of this study was to evaluate the agreement
[16] of urinary CrCl and three commonly used estima-
tion equations, the Cockcroft-Gault (CG) [13], Modifica-
tion of Diet in Renal Disease (MDRD) [14,17,18] and
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) [15] equations, for estimating GFR in com-
parison to GFR measured by the infusion clearance of




The study protocol was approved by the Human Ethics
Committee of the University of Gothenburg. Informed
consent was obtained from the patient or, if the patient
was sedated, the patient’s next of kin, before enrolment
in the study. Thirty patients who developed AKI after
complicated heart surgery were included in the study
according to the following inclusion criteria: cardiac sur-
gery with cardiopulmonary bypass; normal preoperative
renal function (serum creatinine ≤105 μmol/L); and
development of early AKI according to the Acute Kid-
ney Injury Network criteria, defined as a 50% to 300%
postoperative increase in serum creatinine from baseline
[19]. The following exclusion criteria were used: heart
transplantation; thoraco-abdominal aortic surgery; aortic
dissection; use of nephrotoxic drugs, such as radiocon-
trast agents, aminoglycoside antibiotics or nonsteroidal
anti-inflammatory analgesics; or need of dialysis.
In the intensive care unit (ICU), patients who were
mechanically ventilated were sedated with propofol.
Morphine or fentanyl was used for treatment of post-
operative pain. The hemodynamic and renal management
of patients were at the discretion of the attending intensive
care physician. The treatment protocol included inotropic
support with milrinone, dopamine and/or norepinephrine
to maintain a cardiac index ≥2.1 L/min/m2, whole body
oxygen extraction ≤40%, and mean arterial pressure at 70
to 80 mmHg with or without an intra-aortic balloon
pump. A continuous infusion of furosemid (5 to 40 mg/h)
was used, if needed, to promote diuresis. When the patient
was sedated, neurological status was not included in the
sequential organ failure assessment score [20].
Systemic hemodynamics
Arterial blood pressure was measured by a radial or
femoral arterial catheter. All the patients had a central
venous catheter. Systemic hemodynamics were mea-
sured by a pulmonary artery thermodilution catheter
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(Baxter Healthcare Corporation, Irvine, CA, USA) in 21
out of 30 patients. Measurements of thermodilution car-
diac output were performed in triplicate. The pulmonary
artery wedge pressure was measured intermittently.
Systemic vascular resistance was calculated according to
standard formula.
Measurment of serum and urinary creatinine
Blood samples for serum creatinine were taken within a
couple of hours before the experimental procedure. All
serum and urinary creatinine measurements were per-
formed in the same laboratory. Serum and urinary crea-
tinine concentrations were analyzed by a standardized
enzymatic colorimetric method using the Modular P
clinical chemistry analyzer (Roche Diagnostic Scandina-
via AB, Bromma, Sweden)
Assessment of glomerular filtration rate
51Cr-EDTA clearance and urinary creatinine clearance
After blood and urine blanks were taken, an intravenous
priming dose of 51Cr-EDTA (0.6 MBq/m2 body surface
area) was given, followed by an infusion at a constant
rate individualized to body weight and serum creatinine.
Serum 51Cr-EDTA activities from arterial blood were
measured by a well counter (Wizard 300, 1480, Auto-
matic Gamma Counter, PerkinElmer Inc., Turku,
Finland). After an equilibration period of at least 60 min-
utes, urine was collected in two 30-minute periods to
measure urine flow and urine creatinine (period A and
period B). An indwelling Foley catheter drained the
urinary bladder. The levels of 51Cr-EDTA were obtained
from arterial blood at the end of each urine collection
period. Clearance for 51Cr-EDTA was obtained as a






(51Cr− EDTA infusion rate × 1.73) /(







(51Cr− EDTA infusion rate × 1.73) /(
arterial51Cr− EDTA × body surface area
)
The mean of the two 51Cr-EDTA clearances (period A
and B) was used for subsequent comparison with the
urinary CrCl and the estimating equations. Urinary CrCl
was calculated for period A and B from the formula:
CrCl(ml/min /1.73m2)
= (urine volume × urine creatinine × 1.73)/
(serum creatinine × 30 minutes × body surface area)
Estimating equations
GFR was estimated in all patients by the use of three fre-
quently used equations: the CG equation [13], the simpli-
fied refitted MDRD equation [18], and the CKD-EPI
equation [15] (Additional file 1). The CG equation was
calculated with the actual body weight, the preoperative
body weight (to correct for the weight increase due to
edema) and the preoperative ideal body weight (to correct
for overweight), calculated according to a standard for-
mula (Additional file 1). To allow comparison to the
results of other estimating equations, the estimated GFR
(eGFR) from the CG equation was normalized to body
surface area = 1.73 m2. All the equations used for eGFR
are summarized in Additional file 1.
Statistical analysis
Data on hemodynamic and renal variables from periods
A and B were compared using a paired t-test. A prob-
ability level (P-value) of less than 0.05 was considered to
indicate statistical significance. The data are presented
as mean ± standard error of the mean (mean ± SEM).
Descriptive data analyses on the 51Cr-EDTA clearance
method and the urinary CrCl method for measurement
and assessment of GFR were performed according to
Bland and Altman [16]. The (within-method) repeatabil-
ity of each of these two methods were assessed by the
error (double standard deviation of the absolute differ-
ences divided by the mean of the repeated measure-
ments), the repeatability coefficient (the double standard
deviation of the absolute differences) and the mean
coefficient of variation (standard deviation of the mean
divided by the mean of the repeated measurements).
The agreements between the gold standard 51Cr-EDTA
infusion clearance method and the urinary CrCl method,
as well as the estimating equations used for eGFR (the CG
equation, the MDRD equation and the CKD-EPI equa-
tion), were assessed according to Bland and Altman [16].
The mean difference between two methods (bias) and the
standard deviation of the differences were calculated as
well as the error (double standard deviation divided by the
mean of the measurements from the two methods) and
the limits of agreement (mean difference ± two standard
deviations). According to Critchley and Critchley, an
acceptable within-method error was defined as 20% or less
and between-method error as 30% or less [21].
Results
Thirty patients were included in the study, 1 to 12 days
after cardiac surgery. Baseline characteristics of the
patients are presented in Table 1. In the ICU, 23 patients
(77%) were sedated with propofol (52 ±4.6 μg/kg/min)
and mechanically ventilated to normocapnia. Seven
patients (23%) were unsedated and spontaneously
breathing. The serum creatinine increased from a preo-
perative value of 87 ±3 μmol/L to 172 ±9 μmol/L, corre-
sponding to a mean relative increase of 99 ±8% (range:
52% to 245%) on the day of the study. The patients had
a mean sequential organ failure assessment score of
8.6 ±0.38 (range: 5 to 13). Twenty-eight patients (93%)
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were treated with norepinephrine infusion. Eighteen
patients (60%) were treated with milrinone, two (7%)
with dopamine and twenty-seven patients (90%) had fur-
osemide infusion. Six patients (20%) needed an intra-
aortic balloon pump on the day of study. Four patients
(13%) needed dialysis later in the ICU (Table 2). The
30-day postoperative mortality was 20% in this group of
patients.
Individual data on GFR and the various eGFR:s (CrCl,
MDRD, CKD-EPI and CG) are shown in Table 3.
Hemodynamic and renal data obtained during measure-
ment periods A and B are presented in Table 4. With
the exception of heart rate (P = 0.03) there was no sta-
tistically significant differences in hemodynamic data,
plasma 51Cr-EDTA concentrations, GFR measured by
51Cr-EDTA infusion clearance (GFR51Cr-EDTA ) and
eGFR measured by CrCl (eGFRCrCl) between periods A
and B.
Repeatability within methods
As shown in Figure 1, the mean value for GFR51Cr-EDTA
was 47.0 ±18.0 ml/min/1.73m2 and for eGFRCrCl was
43.8 ±21.9 ml/min/1.73m2. The within-group error was
lower for GFR51Cr-EDTA than eGFRCrCl, 7.2% versus
55.0%, respectively. The repeatability coefficient for
GFR51Cr-EDTA and eGFRCrCl were 3.3 and 23.9, respec-
tively, and the mean coefficient of variation for GFR51Cr-
EDTA was lower than the mean coefficient of variation
for eGFRCrCl, 1.73 ±1.38% versus 13.4 ±11.3%.
Agreement between methods
The agreement between measured GFR (GFR51Cr-EDTA)
and estimated GFR (eGFR) with the urinary CrCL
method and the prediction equations (eGFRCG,
eGFRMDRD, eGFRCKD-EPI) are described in Figures 2
and 3. When compared to GFR51Cr-EDTA, the between-
method bias was 2.6 ml/min for eGFRCrCl, 11.6 ml/min
for eGFRMDRD and 11.1 ml/min for eGFRCKD-EPI. The
between-method bias was 7.39 ml/min for eGFRCG
using actual body weight, 7.43 ml/min for eGFRCG
using preoperative body weight and 11.1 ml/min for
eGFRCG using preoperative ideal body weight when
compared to GFR51Cr-EDTA.
The error was 103%, 68.7% and 67.7% for eGFRCrCl,
eGFRMDRD and eGFRCKD-EPI, respectively, when compared
to GFR51Cr-EDTA (Figure 3). The limits of agreement were
-43.9 to 49.1, -16.7 to 39.9 and -17.0 to 39.2 ml/min,
respectively, when compared to GFR51Cr-EDTA. The error
was 68.0%, 66.8% and 67.7%, respectively, and the limits of
agreement were -21.7 to 36.5, -21.5 to 36.3 and -17.0 to
39.1 ml/min for eGFRCG using actual body weight,
eGFRCG using preoperative body weight and eGFRCG
using preoperative ideal body weight when compared to
GFR51Cr-EDTA.
Discussion
In the present study on critically ill patients with early
AKI, the performance of urinary CrCl and various esti-
mation equations for assessment of GFR were compared
to one of the gold standard techniques for measurement
of GFR, the 51Cr-EDTA infusion clearance technique.
The main findings were that urinary CrCl, which has
been used as a reference method, had an unacceptably
low repeatability and that all methods showed a poor
agreement with the gold standard technique and can
therefore not be considered as reliable methods to assess
GFR in critically ill patients with early AKI.
Although commonly used in the ICU, comparisons of
the urinary CrCl method for assessing GFR with gold
standard GFR measurements have not, to our knowl-
edge, previously been reported in critically ill patients
with early AKI. Robert et al. compared urinary CrCl to
inulin clearance in 20 mechanically ventilated, hemody-
namically stable patients not requiring inotropic sup-
port, a minority of whom had acute renal dysfunction
[22]. They found that there was a poor correlation
between both 30-minute and 24-hour urinary CrCl and
Table 1 Baseline characteristics
Preoperative characteristics
Gender, n (% men) 24 (80%)
Age (year) 68.0 ±1.71
Body weight (kg) 87.4 ±2.95
Body surface area (m2) 2.0 ±0.04
Preoperative left ventricular ejection fraction (%) 43 ±3
Diabetes type 2, n (%) 7 (23%)
Hypertension, n (%) 15 (50%)
Preoperative serum creatinine (μmol/L) 86.5 ±3.00
Preoperative Higgins risk score n = 19 3.6 ±0.46
Preoperative treatment:
Angiotensin-converting enzyme inhibitor, n (%) 18 (60%)
Beta-adrenergic blocker, n (%) 24 (80%)
Calcium antagonists, n (%) 3 (10%)
Perioperative characteristics
Type of surgery
Coronary artery bypass surgery, n (%) 12 (40%)
Valve, n (%) 5 (17%))
Combined, n (%) 7 (23%)
Other, n (%) 4 (13%)
Redo CABG/Valve 2 (7%)
Nonelectivea, n (%) 9 (30%)
Cardiopulmonary bypasstime (min) 145.9 ± 12.65
Aortic cross clamp time (min) 81.8 ± 8.88
Intensive care unit Higgins risk score 9.1 ± 0.93
Postoperative (day 1) serum creatinine (μmol/L) 119.2 ±5.59
Data are presented as means ± SEM. a Surgery performed within 24 hours
after referral.
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1 5 65 136 109 2 9 No 0.25 0.00 0 2.53 No
2 2 107 209 95 1 10 Yes 0.16 0.24 0 1.02 No
3 3 109 200 83 1 8 Yes 0.12 0.13 0 0.80 No
4 4 91 151 66 1 12 No 0.14 0.18 0 0.00 No
5 4 102 170 67 1 7 No 0.09 0.00 0 0.99 No
6 6 78 145 86 1 9 No 0.43 0.43 0 0.00 No
7 6 101 194 92 1 7 No 0.22 0.00 0 2.22 No
8 1.5 90 146 62 1 10 Yes 0.33 0.44 0 3.70 No
9 3 81 230 184 2 10 No 0.11 0.52 0 3.06 No
10 6 93 210 126 2 7 No 0.32 0.25 0 1.05 No
11 5 84 217 158 2 9 No 0.27 0.00 0 0.95 No
12 1.5 82 135 65 1 10 No 0.33 0.26 0 3.21 No
13 2 102 155 52 1 10 Yes 0.92 0.26 0 7.41 No
14 4 83 182 119 2 10 No 0.95 0.20 0 6.53 Yes
15 2 81 127 57 1 6 Yes 0.39 0.40 0 2.22 No
16 2 129 233 81 1 11 No 0.54 0.30 2 7.58 No
17 2 79 131 66 1 8 No 0.10 0.00 0 3.06 No
18 1 80 150 88 1 7 No 0.10 0.00 0 4.76 No
19 4 62 134 116 2 10 Yes 0.21 0.50 0 1.14 Yes
20 6 105 184 75 1 4 No 0.00 0.25 0 0.00 No
21 8 105 362 245 3 9 No 0.02 0.35 2 5.34 Yes
22 12 84 187 123 2 9 No 0.05 0.00 0 1.75 No
23 12 63 108 71 1 8 No 0.47 0.00 0 4.14 No
24 1 67 127 90 1 8 No 0.92 0.50 0 3.47 Yes
25 3 69 162 135 2 6 No 0.02 0 0 6.67 No
26 5 79 163 106 2 8 No 0.40 0 0 5.55 No
27 6 64 119 86 1 7 No 0.15 0 0 4.63 No
28 4 99 156 58 1 13 No 0.40 0.50 0 9.44 No
29 8 93 156 68 1 5 No 0 0 0 2.53 No
30 8 69 173 151 2 12 No 0.55 0.20 0 8.58 No
Mean 4.6 ±0.53 86.5 ±3.0 171.7 ±8.96 99.3 ±7.81 8.6 ±0.38 0.32 ±0.05a 0.33 ±0.03a 2.0 ±0.00a 3.86 ±0.49a












Table 3 Individual data on measured and estimated glomerular filtration rates (mL/min/1.73m2) in 30 critically ill
patients
Patient 51Cr-EDTA CrCl MDRD CKD-EPI CG
actual body weight preop body weight ideal body weight
1 39 39 34 35 37 37 34
2 40 31 27 27 29 29 27
3 41 31 29 28 34 35 28
4 76 37 40 40 36 36 39
5 26 49 35 36 50 51 36
6 56 23 41 41 34 34 38
7 42 34 31 31 34 34 34
8 45 46 31 32 39 39 33
9 41 48 25 24 31 30 26
10 27 28 20 19 23 23 19
11 41 29 27 27 31 31 29
12 74 46 46 47 54 54 46
13 47 38 40 41 47 49 42
14 49 12 32 31 35 33 30
15 76 108 50 53 53 53 52
16 36 16 23 22 23 23 21
17 88 57 47 49 55 55 48
18 78 75 40 41 47 47 38
19 40 80 35 36 44 43 45
20 45 43 32 32 35 36 33
21 27 15 14 13 16 16 15
22 33 43 22 21 24 24 21
23 74 43 62 71 72 72 67
24 60 64 49 49 50 50 46
25 35 33 26 26 35 35 23
26 31 71 37 38 45 44 40
27 29 58 51 49 47 46 40
28 28 31 40 42 43 40 45
29 27 70 38 38 36 37 35
30 60 34 39 42 50 52 48
Mean ±SEM 47 ±3 44 ±3 35 ±2 36 ±2 40 ±2 40 ±2 36 ±2
51Cr-EDTA, glomerular filtration rate measured with infusion clearance of 51Cr-EDTA; CG, estimated glomerular filtration rate with the Cockcroft Gault equation
using actual, preoperative (preop) and preoperative ideal body weight; CKD-EPI, estimated glomerular filtration rate with the chronic Kidney Disease
Epidemiology Collaboration equation; CrCl, estimated glomerular filtration rate measured with urinary creatinine clearance; MDRD, estimated glomerular filtration
rate with the Modification of Diet in Renal Disease equation.
Table 4 Hemodynamic and renal data for periods A and B
Period A Period B P
Mean arterial pressure (mmHg) 75.6 ±1.29 73.8 ±1.13 0.10
Cardiac output (L/min), n = 21 5.8 ±0.30 5.8 ±0.31 0.77
Heart rate (beats/min) 94.6 ±3.95 91.2 ±3.22 0.03a
Central venous pressure (mmHg) 11.6 ±0.69 11.8 ±0.76 0.46
Systemic vascular resistance (dynes × sec × cm-5), n = 21 905.3 ±46.0 897.7 ±56.2 0.71
Pulmonary capillary wedge pressure (mmHg) n = 21 16.5 ±1.39 16.3 ±1.34 0.69
Diures (mL/min) 3.87 ±0.32 3.80 ±0.34 0.67
Plasma 51Cr-EDTA 325.0 ±21.5 328.2 ±21.46 0.06
Measured glomerular filtration rate (51Cr-EDTA) (mL/min) 47.3 ±3.37 46.7 ±3.26 0.06
Measured urinary creatinine clearance (mL/min) 45.5 ±4.21 42.7 ±3.91 0.13
Data are presented as means ± SEM. a P <0.05. 51Cr-EDTA, chromium ethylenediaminetetraacetic acid.
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inulin clearance. However, agreement between the two
methods was not tested according to Bland and Altman
[16]. Erley et al. validated 24-hour urinary CrCl to inulin
clearance in 31 ICU patients with a stable (three days)
but wide range of renal (dys)function (serum creatinine:
53 to 590 μmol/l) [12]. Although they did not calculate
the bias or error, they found a mean ratio of CrCl over
inulin clearance of 1.03 with a 95% confidence interval
between 0.54 and 1.92, suggesting a low bias but a high
error, that is, 95% of the CrCl values could be up to
92% higher and 44% lower than the inulin clearance
values. The results of the present study on early AKI are
in line with the data from Erley et al. [12].
In a study of method comparison, assessment of
within-method repeatability is important, because the
repeatability of each of two methods limits the amount
of agreement, which is possible [16,23]. Clearly defined
criteria for an acceptable agreement between two meth-
ods have been lacking since the publication of Bland
and Altman [16]. In an attempt to clarify the criteria for
acceptable agreement between two methods, Critchley
and Critchley suggested that acceptance of a new method
should relay on a between-method error of up to 30%
[21]. They could also demonstrate that the limits of
within-group error of both the test and the reference
method should be 20% or less to achieve a between-
group error of 30% or less. In this study, the repeatability
for 51Cr-EDTA clearance was high, with a within-method
error of only 7.2%. However, urinary CrCl had an unac-
ceptably low repeatability, with a within-method error of
55%. It is therefore not surprising that the agreement
between the 51Cr-EDTA clearance and urinary CrCl was
very low, with an unacceptably high between-method
error of 103%.
The main source of error in the case of urinary CrCl, as
demonstrated by Erley et al. [12] and by the present
study, is probably the collection of urine, despite the fact
that bladder catheters were used for urine collection. We
have previously compared the within-method error of the
urinary clearance of 51Cr-EDTA to that of the infusion
clearance of 51Cr-EDTA measured simultaneously in
ICU patients [24]. The latter method, which was used in
the present study, does not require urine sampling but
requires an equilibrium between the rate of infusion and
excretion of the filtration marker. It was shown that the
within-method error was 33% for the urinary clearance
and 11% for the infusion clearance of 51Cr-EDTA [24].
This illustrates the inherent limitations of urinary clear-
ance methods for the assessment of GFR, irrespective of
the filtration marker used.
Urinary CrCl may grossly overestimate GFR due to
creatinine secretion at the tubular level. The magnitude
of this overestimation increases as GFR declines, and
may be as great as 141% for patients with GFR of <40
mL/min/1.73m2 [25]. Robert et al. [22] compared urin-
ary CrCl to inulin clearance and showed that urinary
CrCl overpredicted GFR when GFR was <40 ml/min,
but underpredicted GFR when GFR was >40 ml/min. In
the present study, the mean GFR, assessed by 51Cr-
EDTA clearance, was approximately 45 to 50 ml/min,
Figure 1 Repeated measurements of glomerular filtration rate. (A) 51Cr-EDTA infusion clearance method and (B) the urinary CrCl method.
The within group error, the repeatability coefficient and the coefficient of variation, is lower for GFR51Cr-EDTA than eGFRCrCl. COV, coefficient of
variation; eGFR; estimated GFR; GFR, glomerular filtration rate; GFR51Cr-EDTA, GFR measured with
51Cr-EDTA infusion clearance; GFRCrCl, GFR
estimated with urinary creatinine clearance.
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which could explain the low bias (2.6 ml/min) compar-
ing urinary CrCl to 51Cr-EDTA clearance.
Disparities between measured GFR and urinary CrCl
in critically ill patients may result from several factors.
Clearance methods require a steady state situation, a cri-
teria not always met in critically ill patients. Variations
in urine output values, due to changes in hormonal
regulation of renal perfusion, changes in systemic hemo-
dynamics, and alterations in creatinine production,
secretion and metabolism, secondary to rapidly evolving
underlying disease states, influence the accuracy of urin-
ary CrCl in critically ill patients [22]. Inaccurate 24-hour
urine collection is also a major pitfall in the determina-
tion of CrCl. A majority of comparative studies con-
ducted in critically ill patients have used 24-hour CrCl
as a reference method [22,26-30]. Shorter timed urine
collection for calculating urinary CrCl is now proposed
to improve clinical utility and diminish procedural error.
Instead of 24-hour urine collection period, we used two
30-minute urine collection periods. Previous studies on
critically ill patients have demonstrated that urinary
CrCl calculated from shorter urine collection periods
show good correlation with those values calculated from
longer urine collection periods [22,26,31-33].
All the GFR estimating equations used in this study, the
CG, MDRD and CKD-EPI equations, performed poorly
when compared to infusion clearance of 51Cr-EDTA
in this group of critically ill patients with early AKI. The
biases ranged from 7.39 ml/min (eGFRCG actual bw) to
11.58 ml/min (eGFRMDRD). The between-group errors
were unacceptably large, ranging from 66.8% to 68.7%,
with wide limits of agreement for all the equations. The
poor performance of the estimating equations in critically
ill patients with early AKI may be explained in part by the
methods and populations used to develop these equations.
All equations were developed and validated in populations
Figure 2 Agreement between measured glomerular filtration rate and estimations from equations. (A) GFR51Cr-EDTA and eGFRCrCl; (B) GFR
51Cr-EDTA and eGFRMDRD; (C) GFR 51Cr-EDTA and eGFRCKD-EPI. GFR, glomerular filtration rate; GFR51Cr-EDTA, GFR measured with
51Cr-EDTA infusion clearance;
GFRCG, GFR estimated with the Cockcroft Gault equation; GFRCKD-EPI, GFR estimated with Chronic Kidney Disease Epidemiology Collaboration equation;
GFRCrCl, GFR estimated with urinary creatinine clearance; GFRMDRD, GFR estimated with the Modification of Diet in Renal Disease equation.
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of non-ICU patients with chronic kidney dysfunction. The
CG equation was originally designed to estimate 24-hour
CrCl, and not GFR, in hospitalized patients with mild renal
dysfunction [13]. The MDRD equation was developed
using urinary 125I-iothalamate clearance as a reference in
1,628 patients with chronic kidney disease [14], and the
CKD-EPI equation was developed using data from 8,254
people with and without chronic kidney failure, using
iothalamate clearance as a reference [15].
Another explanation for the poor performance of the
estimating equations is depressed production of creati-
nine, caused by rapid muscle loss, in ICU patients.
Hoste et al. [34] studied recently admitted critically ill
patients with serum creatinine levels within the normal
range and found that 25% of these patients had a urin-
ary CrCl below 60 ml/min/1.73m2. Urinary creatinine
excretion was low in patients with low CrCl, suggesting
a pronounced muscle loss and depressed production of
creatinine. This could explain why the estimating
equations, based on serum creatinine, overestimated
GFR in the present study.
Estimating equations are also limited by the use of serum
creatinine as a filtration marker. Accurate estimation of
GFR from the serum level of creatinine requires a steady
state. A rise in serum creatinine levels is observed only
after significant loss of kidney function. Thus, serum creati-
nine concentrations lag behind the decline and recovery in
glomerular filtration rate and is affected by factors other
than kidney function, as discussed above for estimating
GFR with the urinary CrCl method in critically ill patients
with AKI. Thus, during non-steady state conditions, using
creatinine-based equations to estimate GFR results in inac-
curate assessment of kidney function [1,22,35].
The estimating equations used in this study, have not
been validated in critically ill patients with early AKI.
Two studies have compared the CG formula to gold
standard reference method in critically ill patients. In
the study by Robert et al. [22], the performance of the
Figure 3 Agreement between measured glomerular filtration rate and estimated rate caluclated using different weights in the CG
equation. (A) GFR51 Cr-EDTA and eGFRCG actual bw; (B) GFR51 Cr-EDTA and eGFRCG preop bw; (C) GFR51 Cr-EDTA and eGFRCG ideal bw. bw, body weight; GFR,
glomerular filtration rate; GFR51Cr-EDTA, GFR measured with
51Cr-EDTA infusion clearance; GFRCG, GFR estimated with the Cockcroft Gault equation.
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CG equation was compared to inulin clearance in 20
critically ill patients not needing inotropic support. They
found that there was a good correlation between inulin
clearance and the CG equation, using the ideal body
weight, and that CG equation can better predict GFR
than urinary CrCl. However, the precision of the CG
equation to predict GFR, that is, the error, was not esti-
mated. In the second study, Erley et al. [12] compared
the CG formula to inulin clearance in 31 critically ill
patients with stable renal function for at least 3 days
before inclusion, and found that the results of the CG
formula were not sufficiently accurate to predict GFR.
The third estimating equation used in this study (CKD-
EPI) has, to our knowledge, not been evaluated against
true measures of GFR in any population of critically ill
patients.
An issue regarding the use of the CG equation, is
which patient weight should be used (actual, preopera-
tive or preoperative ideal body weight), because creati-
nine generation is a function of muscle mass, not body
mass. Recalculating the CG equation with the preopera-
tive body weight and the preoperative ideal body weight,
instead of using the actual weight of the patient, did not
improve the agreement between the CG equation and
the GFR51Cr-EDTA.
Conclusions
The commonly utilized urinary CrCl method for assess-
ment of GFR in critically ill patients with early AKI
shows poor precision. Therefore, it should not be used
as a reference method when validating new methods for
assessing kidney function in this particular patient popu-
lation. Furthermore, the commonly used estimating
equations (CG, MDRD and CKD-EPI equations) per-
form poorly when estimating GFR, with high biases and
unacceptably high errors.
Key messages
In critically ill patients with early AKI:
• Urinary clearance of creatinine should not be used
as a reference method when validating new methods
for assessing kidney function
• Estimating equations for assessment of GFR per-
form poorly.
Additional material
Additional file 1: Supplementary Table 1..
Abbreviations
AKI: acute kidney injury; CG: Cockcroft-Gault equation; CKD-EPI: Chronic
Kidney Disease Epidemiology Collaboration equation; CrCl: creatinine
clearance; 51Cr-EDTA: chromium-ethylenediaminetetraacetic acid; eGFR;
estimated GFR; GFR: glomerular filtration rate; GFR51Cr-EDTA: glomerular
filtration rate measured with chromium-ethylenediaminetetraacetic acid
infusion clearance; GFRCG: glomerular filtration rate estimated with the
Cockcroft-Gault equation; GFRCKD-EPI: glomerular filtration rate estimated with
Chronic Kidney Disease Epidemiology Collaboration equation; GFRCrCl:
glomerular filtration rate estimated with urinary creatinine clearance;
GFRMDRD: glomerular filtration rate estimated with the Modification of Diet in
Renal Disease equation; ICU: intensive care unit; MDRD, Modification of Diet
in Renal Disease equation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors participated in the study design. GB collected and prepared the
data and performed the statistical analysis. GB and BR performed the
experimental procedures. All authors participated in writing the paper and
all read and approved the final manuscript.
Acknowledgements
This study was supported by grants from the Swedish Medical Research
Council, Medical Faculty of Gothenburg (LUA) and Gothenburg Medical
Society. The technical assistance of Mrs Marita Ahlqvist and the assistance of
the nursing staff of the Cardiothoracic Intensive Care Unit and Surgical
Theatre of the Sahlgrenska University Hospital are gratefully acknowledged.
Received: 22 January 2013 Revised: 30 April 2013
Accepted: 15 June 2013 Published: 15 June 2013
References
1. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal
function: new insights into old concepts. Clin Chem 1992, 38:1933-1953.
2. Levey AS: Measurement of renal function in chronic renal disease. Kidney
Int 1990, 38:167-184.
3. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J,
Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US
population: third National Health and Nutrition Examination Survey. Am
J Kidney Dis 1998, 32:992-999.
4. Moran SM, Myers BD: Course of acute renal failure studied by a model of
creatinine kinetics. Kidney Int 1985, 27:928-937.
5. Robert S, Zarowitz BJ: Is there a reliable index of glomerular filtration rate
in critically ill patients? DICP 1991, 25:169-178.
6. Macedo E, Bouchard J, Soroko SH, Chertow GM, Himmelfarb J, Ikizler TA,
Paganini EP, Mehta RL: Fluid accumulation, recognition and staging of
acute kidney injury in critically-ill patients. Crit Care 2010, 14:R82.
7. Dubb JW, Stote RM, Familiar RG, Lee K, Alexander F: Effect of cimetidine
on renal function in normal man. Clin Pharmacol Ther 1978, 24:76-83.
8. Berglund F, Killander J, Pompeius R: Effect of trimethoprim-sulfamethoxazole
on the renal excretion of creatinine in man. J Urol 1975, 114:802-808.
9. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function–
measured and estimated glomerular filtration rate. N Engl J Med 2006,
354:2473-2483.
10. Endre ZH, Pickering JW, Walker RJ: Clearance and beyond: the
complementary roles of GFR measurement and injury biomarkers in
acute kidney injury (AKI). Am J Physiol Renal Physiol 2011, 301:F697-707.
11. Rehberg PB: Studies on kidney function: the rate of filtration and
reabsorption in the human kidney. Biochem J 1926, 20:447-460.
12. Erley CM, Bader BD, Berger ED, Vochazer A, Jorzik JJ, Dietz K, Risler T:
Plasma clearance of iodine contrast media as a measure of
glomerular filtration rate in critically ill patients. Crit Care Med 2001,
29:1544-1550.
13. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum
creatinine. Nephron 1976, 16:31-41.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate
method to estimate glomerular filtration rate from serum creatinine: a
new prediction equation. Modification of Diet in Renal Disease Study
Group. Ann Intern Med 1999, 130:461-470.
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI,
Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to
estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
Bragadottir et al. Critical Care 2013, 17:R108
http://ccforum.com/content/17/3/R108
Page 10 of 11
16. Bland JM, Altman DG: Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986, 1:307-310.
17. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S,
Kusek JW, van Lente F: Using standardized serum creatinine values in the
modification of diet in renal disease study equation for estimating
glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
18. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F:
Expressing the Modification of Diet in Renal Disease Study equation for
estimating glomerular filtration rate with standardized serum creatinine
values. Clin Chem 2007, 53:766-772.
19. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A:
Acute Kidney Injury Network: report of an initiative to improve
outcomes in acute kidney injury. Crit Care 2007, 11:R31.
20. Ceriani R, Mazzoni M, Bortone F, Gandini S, Solinas C, Susini G, Parodi O:
Application of the sequential organ failure assessment score to cardiac
surgical patients. Chest 2003, 123:1229-1239.
21. Critchley LA, Critchley JA: A meta-analysis of studies using bias and
precision statistics to compare cardiac output measurement techniques.
J Clin Monit Comput 1999, 15:85-91.
22. Robert S, Zarowitz BJ, Peterson EL, Dumler F: Predictability of creatinine
clearance estimates in critically ill patients. Crit Care Med 1993,
21:1487-1495.
23. Mantha S, Roizen MF, Fleisher LA, Thisted R, Foss J: Comparing methods of
clinical measurement: reporting standards for bland and altman analysis.
Anesth Analg 2000, 90:593-602.
24. Sward K, Valsson F, Sellgren J, Ricksten SE: Bedside estimation of absolute
renal blood flow and glomerular filtration rate in the intensive care unit.
A validation of two independent methods. Intensive Care Med 2004,
30:1776-1782.
25. Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as
a measurement of glomerular filtration rate. Am J Kidney Dis 1982,
2:337-346.
26. Herrera-Gutierrez ME, Seller-Perez G, Banderas-Bravo E, Munoz-Bono J,
Lebron-Gallardo M, Fernandez-Ortega JF: Replacement of 24-h creatinine
clearance by 2-h creatinine clearance in intensive care unit patients: a
single-center study. Intensive Care Med 2007, 33:1900-1906.
27. Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I: Augmented renal
clearance in the critically ill: how to assess kidney function. Ann
Pharmacother 2012, 46:952-959.
28. Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J: A
comparison of estimates of glomerular filtration in critically ill patients
with augmented renal clearance. Crit Care 2011, 15:R139.
29. Bouchard J, Macedo E, Soroko S, Chertow GM, Himmelfarb J, Ikizler TA,
Paganini EP, Mehta RL: Comparison of methods for estimating glomerular
filtration rate in critically ill patients with acute kidney injury. Nephrol
Dial Transplant 2010, 25:102-107.
30. Martin C, Alaya M, Bras J, Saux P, Gouin F: Assessment of creatinine
clearance in intensive care patients. Crit Care Med 1990, 18:1224-1226.
31. Baumann TJ, Staddon JE, Horst HM, Bivins BA: Minimum urine collection
periods for accurate determination of creatinine clearance in critically ill
patients. Clin Pharm 1987, 6:393-398.
32. Sladen RN, Endo E, Harrison T: Two-hour versus 22-hour creatinine
clearance in critically ill patients. Anesthesiology 1987, 67:1013-1016.
33. Wilson RF, Soullier G: The validity of two-hour creatinine clearance
studies in critically ill patients. Crit Care Med 1980, 8:281-284.
34. Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, van den
Hauwe K, Colardyn FA: Assessment of renal function in recently admitted
critically ill patients with normal serum creatinine. Nephrol Dial Transplant
2005, 20:747-753.
35. Sirota JC, Klawitter J, Edelstein CL: Biomarkers of acute kidney injury.
J Toxicol 2011, 2011:328120.
doi:10.1186/cc12777
Cite this article as: Bragadottir et al.: Assessing glomerular filtration rate
(GFR) in critically ill patients with acute kidney injury - true GFR versus
urinary creatinine clearance and estimating equations. Critical Care 2013
17:R108.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bragadottir et al. Critical Care 2013, 17:R108
http://ccforum.com/content/17/3/R108
Page 11 of 11
